What’s The Plan, Ronna?
You're Not Going to Be Able to Keep Your Job in Broadcast Media...
Sick of the Moral Preening of Conservatives After Every Loss
Is the Sleeping Conservative Dragon Finally Waking Up?
The Supreme Court Finally Reins in EPA Water Czars
GOP Congressman Makes Retirement Announcement
Raising the Debt Ceiling is Nothing but Government Theft
Death of the Professions
Yes We Fight, But Not With the Weapons of the World
Protecting our Kids’ Mental Health by Protecting their Sexual Health
Some Democrats Give Hypocrisy A Bad Name On Education
Time to Fully Support Our Drug Enforcers – If Not Now, When?
A Conversation With Lt. Col. Oliver North
The Founders and Religious Liberty
CUNY Law: A Graduation Under Siege

Stocks in the News: VF Corp, AbbVie, D.R. Horton

The opinions expressed by columnists are their own and do not necessarily represent the views of Townhall.com.

Welcome to John Ransom's Stocks In The News, where the headline meets the trendline.

Stocks in the News is produced by Ransom Notes Radio and Goodfellow, LLC. Crista Huff manages Goodfellow LLC, a website that recommends outperforming stocks using fundamental and technical analysis.            

Stock number one is:

V.F. Corp.(SYMBOL: VFC), and the headline says:

Strong First Quarter Beat  (Citi Research)

V.F. Corp., maker of Wrangler, Lee, The North Face and Timberland apparel, announced first quarter earnings per share of $2.43, handily beating the consensus estimate of $2.19.  Gross margins expanded 240 basis points year-over-year to a new high of 48.1%, reports Citi Research.

Wall Street projects V.F. Corp to grow earnings 12-13% per year for the next three years.  The dividend yield is 2%.

We recommended a “buy” on V.F. Corp. on February 15.  The stock is up $16 since then.  Growth stock investors and growth & income investors should jump in here.

Our Ransom Note trendline says:  BUY V.F. CORP.

VFC Chart

VFC data by YCharts

Stock number two is: 

Stock number two is AbbVie Inc. (SYMBOL: ABBV), and the headline says:

AbbVie Profit Beats Analysts’ Estimates in First Quarter  (Bloomberg)

“AbbVie Inc. reported earnings that beat analysts’ estimates on higher sales of the rheumatoid arthritis treatment Humira in the first quarter since the drugmaker was split from parent Abbott Laboratories,” reports Bloomberg.  Prospects for Humira sales continue to grow with potential treatments for Hepatitis C, psoriasis and ulcerative colitis.

Earnings are projected to grow 3% this year.  The dividend yield is 3.54%, and the long-term debt ratio is 81%.

The stock broke past $39 on March 25, and is still on an uptrend.  Growth & income investors should retain their shares, but be aware that eps growth is slow and debt is high.

Our Ransom Note trendline says:  HOLD ABBVIE SHARES.

ABBV Chart

ABBV data by YCharts

Stock number three is:

Stock number three is D.R. Horton (SYMBOL: DHI), and the headline says:

D.R. Horton Profit More Than Doubles on Rising Home Sales  (Bloomberg)

D.R. Horton Inc., the largest U.S. homebuilder by volume, reported a blowout second quarter on increased volume and gross margins.  Earnings per share came in at 32 cents vs. analysts’ expected 19 cents, and 13 cents a year ago.  New home closings rose to 5,643; 9% higher than the market expected; and SG&A expenses were 5% lower than expected.

Earnings are projected to grow between 44% and 51% per year for each of the next three years.

The stock appears to be breaking out today, after trading between $21 and $25 for three months.  There is additional price resistance at $30.  On February 26, we told investors to “buy now at $22”.  We reiterated our Buy recommendation on March 26.

Our Ransom Note trendline says:  BUY D.R. HORTON.

DHI Chart

DHI data by YCharts

Join the conversation as a VIP Member


Trending on Townhall Video